Structure of Bergapten
CAS No.: 484-20-8
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo and inhibits proliferation in the human hepatocellular carcinoma cell line.
Synonyms: 5-Methoxypsoralen; 5-MOP; NSC 95437
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 484-20-8 |
Formula : | C12H8O4 |
M.W : | 216.19 |
SMILES Code : | O=C1C=CC2=C(O1)C=C(OC=C3)C3=C2OC |
Synonyms : |
5-Methoxypsoralen; 5-MOP; NSC 95437
|
MDL No. : | MFCD00010272 |
InChI Key : | BGEBZHIAGXMEMV-UHFFFAOYSA-N |
Pubchem ID : | 2355 |
GHS Pictogram: |
![]() ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335-H351-H361 |
Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
HFOB | 200-400 µM | 48 hours | To evaluate cytotoxicity | PMC10647757 |
HSF | 200-400 µM | 48 hours | To evaluate cytotoxicity | PMC10647757 |
U266 | 1190 µM (IC50) | 96 hours | Inhibited cell proliferation | PMC10647757 |
HUVEC cells | 2.5-40 μM | 12 or 24 hours | To evaluate the biocompatibility of Ber-lipo, results showed that Ber-lipo had good biocompatibility and Lipo significantly reduced the cytotoxicity of bergapten. | PMC11474395 |
RAW264.7 cells | 2.5-40 μM | 12 or 24 hours | To evaluate the biocompatibility of Ber-lipo, results showed that Ber-lipo had good biocompatibility and Lipo significantly reduced the cytotoxicity of bergapten. | PMC11474395 |
Bone marrow-derived macrophages (BMDMs) | 20 μM | 2 hours | Inhibited NLRP3 inflammasome activation, evidenced by attenuated cleaved caspase-1 and mature IL-1β release, as well as reduced ASC speck formation and subsequent gasdermin D (GSDMD)-mediated pyroptosis. | PMC10462717 |
J774A.1 cells | 20 μM | 2 hours | Inhibited NLRP3 inflammasome activation, evidenced by attenuated cleaved caspase-1 and mature IL-1β release, as well as reduced ASC speck formation and subsequent gasdermin D (GSDMD)-mediated pyroptosis. | PMC10462717 |
RAW264.7 macrophages | 62.5, 125, 250 μM | 24 hours | To evaluate the effect of Bergapten on NO and PGE2 production in RAW264.7 cells. Results showed that Bergapten significantly inhibited LPS-induced NO and PGE2 production. | PMC9146895 |
Recombinant human CYP3A4 (rCYP3A4) | 1.424 μM (IC50) | 30 minutes | Bergapten significantly inhibited the metabolism of tofacitinib in recombinant human CYP3A4, showing competitive inhibition | PMC11033359 |
Human liver microsomes (HLMs) | 2.647 μM (IC50) | 30 minutes | Bergapten significantly inhibited the metabolism of tofacitinib in human liver microsomes, showing competitive inhibition | PMC11033359 |
Rat liver microsomes (RLMs) | 2.619 μM (IC50) | 30 minutes | Bergapten significantly inhibited the metabolism of tofacitinib in rat liver microsomes, showing competitive inhibition | PMC11033359 |
B16F10 melanoma cells | 6.25, 12.5, 25 μM | 48 hours | To evaluate the effect of Bergapten on the expression of melanogenesis-related proteins, results showed that Bergapten significantly increased the protein expression levels of MITF, tyrosinase, TRP-1, and TRP-2. | PMC9102055 |
B16F10 melanoma cells | 6.25, 12.5, 25 μM | 48 hours | To evaluate the effect of Bergapten on the expression of melanogenesis-related proteins, results showed that Bergapten increased the expression of MITF, tyrosinase, TRP-1, and TRP-2. | PMC9102055 |
ZR-75 | 20 μM and 50 μM | 6 to 16 hours | Bergapten induces autophagy by up-regulating PTEN expression, increasing Beclin1, PI3KIII, UVRAG, AMBRA expression and conversion of LC3-I to LC3-II | PMC4498523 |
MCF-7 | 20 μM and 50 μM | 6 to 16 hours | Bergapten induces autophagy by up-regulating PTEN expression, increasing Beclin1, PI3KIII, UVRAG, AMBRA expression and conversion of LC3-I to LC3-II | PMC4498523 |
B16F10 melanoma cells | 6.25, 12.5, 25 μM | 72 hours | To evaluate the effect of Bergapten on melanogenesis, results showed that Bergapten significantly increased melanin content and tyrosinase activity. | PMC9102055 |
B16F10 melanoma cells | 1, 10, or 100 μM | To evaluate the effect of Bergapten on melanin content and tyrosinase activity, results showed that Bergapten dose-dependently increased melanin content and tyrosinase activity in B16F10 cells | PMC6812039 | |
Rabbit jejunum | 0.0026 mg/ml | Bergapten exhibited concentration-dependent relaxation of both spontaneous and K+-induced contractions, similar to the effect of papaverine | PMC9709249 | |
RPMI8226 | 1272 µM (IC50) | 96 hours | Inhibited cell proliferation | PMC10647757 |
SW620 | 354.5 µM (IC50) | 96 hours | Inhibited cell proliferation | PMC10647757 |
HT-29 | 332.4 µM (IC50) | 96 hours | Inhibited cell proliferation | PMC10647757 |
HOS | 257.5 µM (IC50) | 96 hours | Inhibited cell proliferation | PMC10647757 |
Saos-2 | 40.05 µM (IC50) | 96 hours | Inhibited cell proliferation, induced apoptosis | PMC10647757 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Mice | High-fat diet and streptozotocin-induced diabetic mice | Dietary supplementation | 0.02% (w/w) | For 10 weeks | To evaluate whether bergapten and methoxsalen could prevent diabetes-induced osteoporosis and its underlying mechanism. Results showed that both bergapten and methoxsalen significantly reversed the decrease in serum osteocalcin, bone-alkaline phosphatase, and femur BMD, increased bone volume density and trabecular number, while decreasing the structure model index of femur tissue in diabetic mice. Additionally, these derivatives significantly reduced the number and formation of osteoclasts in diabetic bone tissue and downregulated the expression of osteoclast-related genes. | PMC6471636 |
C57BL/6 mice | Vitiligo model | Transdermal administration | 1% (w/w) | Once daily for 12 days | To evaluate the effect of Bergapten on hair pigmentation in vitiligo model mice, results showed that Bergapten significantly improved hair pigmentation | PMC6812039 |
C57/B6 mice | High-fat diet-induced diabetes-related osteoporosis model | Oral | 10 mg/kg/day and 20 mg/kg/day | Once daily for 20 weeks | Bergapten significantly inhibited RANKL-RANK signaling transduction, and suppressed the activation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways, thus protecting trabecular structure and decreasing osteoclastogenic differentiation | PMC5117769 |
Sprague Dawley rats | Drug interaction model | Oral | 20 mg/kg and 50 mg/kg | Single dose | Bergapten significantly increased the plasma exposure (AUC) and maximum concentration (Cmax) of tofacitinib and decreased clearance (CLz/F), indicating inhibition of tofacitinib metabolism in vivo | PMC11033359 |
C57BL/6J mice | Escherichia coli-induced sepsis model | Intraperitoneal injection | 50 mg/kg | 24 hours and 1 hour before injection | Significantly ameliorated tissue inflammation and injury. | PMC10462717 |
Mice | Castor oil-induced diarrhea model | Oral | 50, 100, 200 mg/kg | Single dose, observed for 4 hours | Bergapten at doses of 50-200 mg/kg effectively reduced diarrheal secretions and intestinal secretions, showing antidiarrheal and antisecretory effects | PMC9709249 |
Heracleum sosnowskyi | Plant leaves | Natural exposure to high temperature | 2 days and 7 days | To study the effect of high temperature on the content of Bergapten in Heracleum sosnowskyi, the results showed that the content of Bergapten significantly increased after 2 days and 7 days of high temperature treatment. | PMC8124411 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00533195 | Atopic Dermatitis | Phase 3 | Completed | - | Austria ... More >> Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology Vienna, Austria, 1090 Less << |
NCT00811005 | Pustular Palmoplantar Psoriasi... More >>s Less << | Phase 3 | Unknown | October 2010 | Austria ... More >> Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology Vienna, Austria, 1180 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
4.63mL 0.93mL 0.46mL |
23.13mL 4.63mL 2.31mL |
46.26mL 9.25mL 4.63mL |
Tags: Bergapten | 5-Methoxypsoralen | Cytochrome P450 | Autophagy | CYPs | cytochrome P450 inhibitor | CYP1A2 inhibitor | CYP2A6 inhibitor | drug metabolism | photochemotherapy | 484-20-8
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL